Oragenics resumes Phase ll trial of AG013 for oral mucositis
Oragenics has resumed its Phase ll clinical trial of AG013 for the treatment of oral mucositis (OM), after a positive…
oral mucositis Oragenics AG013
Oragenics has resumed its Phase ll clinical trial of AG013 for the treatment of oral mucositis (OM), after a positive…